Septerna Insiders Enjoying US$951k Appreciation On US$934.3k Investment - simplywall.st
20 hours ago • Google News
Septerna, Inc. Common Stock (SEPN)
US$ 6.460%
Price Chart
Key Statistics
Market Cap
$ 444.25M
P/E Ratio
0.00
Revenue (TTM)
$ 977K
Volume
173.34K
52W High
$ 28.99
52W Low
$ 4.17
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
6.5483
200-Day MA
14.2869
52 Week High
28.99
52 Week Low
4.17
About SEPN
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflamm.
Employees
75
Headquarters
South San Francisco, CA
CEO
Dr. Jeffrey T. Finer M.D., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg